Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

GUFIC BIOSCIENCE Gains 5%; BSE HEALTHCARE Index Down 0.1%
Thu, 22 Aug 10:19

GUFIC BIOSCIENCE Gains 5%; BSE HEALTHCARE Index Down 0.1%Image source: Nikada/www.istockphoto.com

GUFIC BIOSCIENCE share price has zoomed 5% and is presently trading at Rs 382.9.

Meanwhile, the BSE HEALTHCARE index is at 41,979.4 (down 0.1%).

Among the top gainers in the BSE HEALTHCARE index today are AARTI DRUGS (up 7.6%) and HIKAL CHEMIC (up 3.2%).

GSK Pharma (down 2.9%) and Procter & Gamble Health (down 2.7%) are among the top losers today.

Over the last one year, GUFIC BIOSCIENCE has moved up from Rs 260.6 to Rs 382.9, registering a gain of Rs 122.3 (up 46.9%).

On the other hand, the BSE HEALTHCARE index has moved up from 28,021.8 to 41,979.4, registering a gain of 49.8% during the last 12 months.

The top gainers among the BSE HEALTHCARE index stocks during this same period were GRANULES INDIA (up 130.7%), Glenmark Pharma (up 114.6%) and GSK Pharma (up 111.9%).

Must See: These Segments are Witnessing Incredible Growth with Modi's Push

What About the Benchmark Indices?

The BSE Sensex is at 81,033.2 (up 0.2%).

The top gainers among the BSE Sensex today are Bharti Airtel (up 1.0%) and Asian Paints (up 0.9%). The most traded stocks in the BSE Sensex are Bharti Airtel and Tata Steel.

In the meantime, NSE Nifty is at 24,813.8 (up 0.2%). Grasim Industries and Tata Consumer Products are among the top gainers in NSE NIFTY.

Over the last 12 months, the BSE Sensex has moved up from 65,216.1 to 81,033.2, registering a gain of 15,817.1 points (up 24.3%).

GUFIC BIOSCIENCE Financial Update...

GUFIC BIOSCIENCE net profit grew 1.1% YoY to Rs 209 million for the quarter ended June 2024, compared to a profit of Rs 206 million a year ago. Net sales rose 4.0% to Rs 2,028 million during the period as against Rs 1,950 million in April-June 2023.

For the year ended March 2023, GUFIC BIOSCIENCE reported 16.8% decrease in net profit to Rs 797 million compared to net profit of Rs 958 million during FY22. Revenue of the company fell 11.4% to Rs 6,906 million during FY23.

The current Price to earnings ratio of GUFIC BIOSCIENCE, based on rolling 12 month earnings, stands at 44.5.


Equitymaster requests your view! Post a comment on "GUFIC BIOSCIENCE Gains 5%; BSE HEALTHCARE Index Down 0.1%". Click here!